Belgium - Immunoglobulins

For more information and to make a bid you will need to go to the third party website.

Details

Provided by Open Opps
Opportunity closing date
16 August 2022
Opportunity publication date
05 July 2022
Category
33651520
Value of contract
to be confirmed
Your guide to exporting
Report opportunity

Description

Hospitals must purchase the portion not covered by the national government contract for processing plasma supplied by blood establishments in Belgium and ensuring adequate supply to hospitals of stable plasma derivatives (albumin solutions and immunoglobulins for intravenous administration) manufactured from the plasma supplied under the supervision of the FPS Public Health, Food Chain Safety and Environment (ref: FPS VVVL-PLASMADERIVATEN/2021/01-F03_0). To this end, the present framework agreement is being put on the market. The aim is to conclude a framework agreement not only for the supply of polyvalent human immunoglobulins but also for prothrombin complex concentrate and fibrinogen.
Concerns the purchase of low concentrated immunoglobulins <= 5% Concerns the purchase of polyvalent high concentrated ( >5%) immunoglobulins for iv for the northern hospital network of Limburg. Concerns the purchase of Polyvalent highly concentrated ( >5%) immunoglobulins for iv for the southern hospital network of Limburg. Concerns the purchase of Polyvalent highly concentrated (>5%) immunoglobulins for iv with IgA content < 20 micrograms/ml. Concerns the purchase of Protrombin complex concentrate. Concerns the purchase of phybrinogen.

Opportunity closing date
16 August 2022
Value of contract
to be confirmed

About the buyer

Address
Hospilim VZW Bioville, Agoralaan Abis Diepenbeek 3590 Belgium
Contact
debbie.smets@hospilim.be

The deadline to apply for this opportunity has passed.
Visit the opportunities page to find another.

Is there anything wrong with this page?